Tumor vaccine development from dendritic cell-tumor cell fusions

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		06-34
IP Type:		Licensable Technology
Title:		Tumor vaccine development from dendritic cell-tumor cell fusions
Inventor:		Gong, Jianlin
Summary:		Heat shock protein 70 (HSP70) peptide complexes derived from the fusion of dendritic cells and tumor cells are superior cancer vaccines than HSP70 peptide complexes from tumor cells alone.
Tech Type:		Therapeutics - Methods
URL:		http://ctf-fmfe.bu.edu/BU0634.pdf
Contact:		Rick T. Clark, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Gong, Jianlin
Display all intellectual properties for Boston University